These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A cost--benefit analysis for a multimodality heroin treatment project. Sirotnik KA, Bailey RC. Int J Addict; 1975 Sep 20; 10(3):443-51. PubMed ID: 809366 [No Abstract] [Full Text] [Related]
43. Availability of activity reinforcers in a drug abuse clinic: a preliminary report. Yen S. Psychol Rep; 1974 Jun 20; 34(3):1021-22. PubMed ID: 4846904 [No Abstract] [Full Text] [Related]
44. Drug abuse: models of treatment and their consequences. Lief VF. Int Pharmacopsychiatry; 1972 Jun 20; 7(1-4):7-21. PubMed ID: 4619399 [No Abstract] [Full Text] [Related]
46. Need conflicts of suburban narcotic abusers who apply to a county methadone maintenance program. Sheppard C, Ricca E, Fracchia J, Merlis S. J Clin Psychol; 1975 Jan 20; 31(1):140-5. PubMed ID: 1112892 [No Abstract] [Full Text] [Related]
47. Proceedings: How can we compare the effectiveness of different programs and modalities? Barr HL. Am J Drug Alcohol Abuse; 1976 Jan 20; 3(1):103-14. PubMed ID: 59543 [No Abstract] [Full Text] [Related]
49. Impact of a large-scale narcotics treatment program: a six month experience. Brown BS, DuPont RL, Bass UF, Brewster GW, Glendinning ST, Kozel NJ, Meyers MB. Int J Addict; 1973 Jan 20; 8(1):49-57. PubMed ID: 4713704 [No Abstract] [Full Text] [Related]
50. Drug treatment programs in Pennsylvania. A statewide evaluation. Ball JC, Graff H. Am J Public Health; 1975 Jun 20; 65(6):592-8. PubMed ID: 1093419 [No Abstract] [Full Text] [Related]
51. A revised treatment typology based on the DARP. Cole SG, James LR. Am J Drug Alcohol Abuse; 1975 Jun 20; 2(1):37-49. PubMed ID: 1190193 [No Abstract] [Full Text] [Related]
52. Proceedings: Cost savings/benefit analysis of drug abuse treatment. Scanlon JC. Am J Drug Alcohol Abuse; 1976 Jun 20; 3(1):95-101. PubMed ID: 820188 [No Abstract] [Full Text] [Related]
53. The impact of drug treatments on during-treatment criteria: 1971-1972 DARP admissions. Gorsuch RL. Am J Drug Alcohol Abuse; 1975 Jun 20; 2(1):73-98. PubMed ID: 1190196 [No Abstract] [Full Text] [Related]
55. Assessment of treatment outcomes in a drug abuse rehabilitation network: Newark, New Jersey. Sheffet AM, Quinones MA, Doyle KM, Lavenhar MA, Nakah AE, Louria DB. Am J Drug Alcohol Abuse; 1980 Jun 20; 7(2):141-73. PubMed ID: 7446508 [No Abstract] [Full Text] [Related]
56. The methadone method. Whyman JS, Woody GE, Patch VD. N Engl J Med; 1972 Mar 30; 286(13):728-9. PubMed ID: 5061064 [No Abstract] [Full Text] [Related]
57. Attitudes toward drug abuse among residents in a therapeutic community. Hart L. Int J Addict; 1973 Mar 30; 8(5):809-20. PubMed ID: 4781418 [No Abstract] [Full Text] [Related]
58. Health insurance for drug addiction: a survey. Muller C. Am J Psychiatry; 1972 Jun 30; 128(12):1516-23. PubMed ID: 5025272 [No Abstract] [Full Text] [Related]
59. Federal drug abuse policy and minority group issues--reflections of a participant-observer. Brown BS. Int J Addict; 1985 Jan 30; 20(1):203-15. PubMed ID: 3888861 [No Abstract] [Full Text] [Related]
60. Drug abuse treatment. Phillipson R. J Sch Health; 1972 Dec 30; 42(10):625-8. PubMed ID: 4485227 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]